FDA Drug Application (021726) for NIRAVAM by UCB INC

Back to FDA Applications sponsored by UCB INC

Application Number021726
Product Number001
FormTABLET, ORALLY DISINTEGRATING;ORAL
Dosage0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameNIRAVAM
Active IngredientALPRAZOLAM

Active IngredientCount
List of drugs with Active Ingredient ALPRAZOLAM4


Back to FDA Applications sponsored by UCB INC